RE: here we go7 Sep 2022 11:39
The 25,640,254 Options in IMM originally held equally by L1 and Lind, had to be exercised by 10 June 2023, with an exercise price of 11 pence. The result of the placing was that they could not be redeemed and so they amended the exercise price from 11 pence to 5 pence and increased the number of Options held by L1 and Lind from 25,640,254 to 56,408,558.
Luckily, the the Benchmark Price in relation to the 2021 Sharing Agreement wasn't also increased by 50 per cent. from 14.6667 pence to 22 pence.
I agree with posters like @maestro1, that the most recent placing was not required before the FDA decision. Both that, and the recent exercising of Options does suggest some positioning by insiders to profit once news lands. This is AIM, so we are used to seeing people get their snouts and just have to hold our nose.
I appreciate that the Options exercised so far may be forward sold in anticipation, however the amount of Options being exercised to date are relatively small to the number held. Main question is at what point will we see selling into any expected rise. SP seems to be taking developments in their stride so hopefully we can get into the teens, and finally achieve the Benchmark price which one would hope is an aspiration of TM's.